Fresenius Medical Care AG ADR (NYSE:FMS) shares, rose in value on Friday, May 30, with the stock price down by -0.87% to the previous day’s close as strong demand from buyers drove the stock to $28.40.
Actively observing the price movement in the last trading, the stock closed the session at $28.65. The PE ratio was 25.02 over 12-month period. Referring to stock’s 52-week performance, its high was $30.46, and the low was $17.93. On the whole, FMS has fluctuated by 11.90% over the past month.
With the market capitalization of Fresenius Medical Care AG ADR currently standing at about $16.67 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June. The company’s Forward Dividend Ratio is 0.79, with its dividend yield at 2.77%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that FMS’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.49, with the price of FMS currently trading nearly 0.19% and 9.45% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 56.98, while the 7-day volatility ratio is showing 1.67% which for the 30-day chart, stands at 2.06%. Furthermore, Fresenius Medical Care AG ADR (FMS)’s beta value is 0.86, and its average true range (ATR) is 0.63.
A comparison of Fresenius Medical Care AG ADR (FMS) with its peers suggests the former has fared considerably weaker in the market. FMS showed an intraday change of -0.87% in last session, and over the past year, it grew by 33.15%%.
Data on historical trading for Fresenius Medical Care AG ADR (NYSE:FMS) indicates that the trading volumes over the past 3 months, they’ve averaged 459.44K. According to company’s latest data on outstanding shares, there are 586.83 million shares outstanding.
Nearly 0.07% of Fresenius Medical Care AG ADR’s shares belong to company insiders and institutional investors own 5.99% of the company’s shares. The stock has risen by 25.44% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the FMS stock heading into the next quarter.
